Genetic influence in liver steatosis prevalence and proatherothrombotic/inflammatory profile in familial combined hyperlipoproteinemia-Reference-Cited by-同舟云学术

Genetic influence in liver steatosis prevalence and proatherothrombotic/inflammatory profile in familial combined hyperlipoproteinemia

Published:2013-09 Issue:1 Volume:168 Page:536-539
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Santilli Francesca,Blardi Patrizia,Scarpini Francesca,Acciavatti Angela,Ceccatelli Linda,Magliocca Antonio,Avolio Tiziana,Bocchia Monica,Scapellato Carlo,Gioffrè Walter Renato,Auteri Alberto,Ferracane Silvia Cristina,Puccetti Luca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case–control comparison from the National Heart, Lung, and Blood Institute Family Heart Study;Hopkins;Circulation,2003

2. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study;Veerkamp;Arterioscler Thromb Vasc Biol,2002

3. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia;Ayyobi;Arterioscler Thromb Vasc Biol,2003

4. The genetics of familial combined hyperlipidaemia;Brouwers;Nat Rev Endocrinol,2012

5. Atherosclerosis and Metabolic Diseases Study Group. Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date;Gaddi;Vasc Health Risk Manag,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome;Vascular Pharmacology;2015-09